Michaud Charles Jr 4
4 · Homology Medicines, Inc. · Filed Jan 3, 2024
Insider Transaction Report
Form 4
Michaud Charles Jr
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2024-01-01+2,640→ 13,306 total - Exercise/Conversion
Common Stock
2024-01-01+544→ 9,610 total - Exercise/Conversion
Restricted Stock Units
2024-01-01−544→ 0 total→ Common Stock (544 underlying) - Exercise/Conversion
Restricted Stock Units
2024-01-01−2,640→ 5,360 total→ Common Stock (2,640 underlying) - Exercise/Conversion
Common Stock
2024-01-01+1,056→ 10,666 total - Exercise/Conversion
Restricted Stock Units
2024-01-01−1,056→ 1,088 total→ Common Stock (1,056 underlying)
Footnotes (4)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
- [F2]The RSUs vested and settled in full on January 1, 2024. The RSUs do not have an expiration date.
- [F3]The RSUs have vested and settled or will vest and settle as to 1,056 shares on January 1, 2024 and 1,008 shares on January 1, 2025. The RSUs do not have an expiration date.
- [F4]The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2023 so that such RSUs will become fully vested on January 1, 2026. The RSUs do not have an expiration date.